Off-target effects of mitochondrial oxidative phosphorylation inhibitors are common and can compromise the viability of cultured cells
Mitochondrial Communications · 2025 · 3 · 99-108
DOI: 10.1016/j.mitoco.2025.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mitochondrial Communications, 2025. Verfasst von Natalya Kozhukhar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, University of South Alabama, Mobile, AL, 36688, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health Office of the Director.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, University of South Alabama, Mobile, AL, 36688, USA.
ORCID-Profile: Mikhail F Alexeyev
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health Office of the Director
- National Science Foundation
- US Office of Congressionally Directed Medical Research Programs
Zitieren
APA
Kozhukhar, N., & Alexeyev, M. F. (2025). Off-target effects of mitochondrial oxidative phosphorylation inhibitors are common and can compromise the viability of cultured cells. Mitochondrial Communications, 3, 99-108. https://doi.org/10.1016/j.mitoco.2025.12.001
Vancouver
Kozhukhar N, Alexeyev MF. Off-target effects of mitochondrial oxidative phosphorylation inhibitors are common and can compromise the viability of cultured cells. Mitochondrial Communications. 2025;3:99-108. doi:10.1016/j.mitoco.2025.12.001
BibTeX
@article{Kozhukhar2025,
author = {Kozhukhar, Natalya and Alexeyev, Mikhail F},
title = {Off-target effects of mitochondrial oxidative phosphorylation inhibitors are common and can compromise the viability of cultured cells},
journal = {Mitochondrial Communications},
year = {2025},
volume = {3},
pages = {99--108},
doi = {10.1016/j.mitoco.2025.12.001}
}
EUVIMED